Detection of myelin basic protein in cerebrospinal fluid

Expert Review of Molecular Diagnostics

Volumn 2, Issue 6, 2002, Pages 627-633

  Ohta, Mitsuhiro ^a   Ohta, Kiyoe ^b  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^b UTANO NATIONAL HOSPITAL   (Japan)

Author keywords

Cerebrospinal fluid; Enzyme linked immunosorbent assay; Human T cell lymphotropic virus; Multiple sclerosis; Myelin basic protein; Type I associated myelopathy tropical spastic paraparesis

Indexed keywords

MYELIN BASIC PROTEIN; AUTOANTIGEN;

ARTICLE; CEREBROSPINAL FLUID ANALYSIS; DEMYELINATION; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PROTEIN DETERMINATION; RADIOIMMUNOASSAY; RELAPSE; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; ADOLESCENT; ADULT; AGED; ANALYTICAL EQUIPMENT; ANIMAL; AUTOIMMUNE DISEASE; CATTLE; CEREBROSPINAL FLUID; COMPARATIVE STUDY; DISEASE COURSE; FEMALE; FORECASTING; LONGITUDINAL STUDY; MALE; METHODOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; CATTLE; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FORECASTING; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; NERVOUS SYSTEM DISEASES; PARAPARESIS, TROPICAL SPASTIC; REAGENT KITS, DIAGNOSTIC;

EID: 0036854238     PISSN: 14737159     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.2.6.627     Document Type: Article

References (25)

1. Norton WT. Formation, structure and biochemistry of myelin. In: Basic Neurochemistry (3rd Ed.) Seigel GJ, Albers, RW, Agranoff BW, Karzman RT, (Eds.), Little Brown, Boston, MA, USA 63-92 (1981).
2. Cohen SR, Herndon RM, McKhann GM. Radioimmunoassay of myelin basic protein in spinal fluid: An index of active demyelination. N. Engl. J. Med. 295, 1455-1457 (1976). One of the RIA reports in which patients with active demyelinating diseases had high levels of MBP, and also patients with mutiple sclerosis had high levels of MBP in acute exacerbation and low levels in remission.
3. Whitaker JN. Myelin encephalitogenic protein fragments in cerebrospinal fluid of persons with multiple sclerosis. Neurology 27, 911-920 (1977). Reports a double-antibody RIA system measuring MBP in unconcentrated CSF.
4. Carson JH, Barbarese E, Braun PE, McPherson TA. Components in multiple sclerosis cerebrospinal fluid that are detected by radioimmunoassay for myelin basic protein. Proc. Natl. Acad. Sci. USA 75, 1976-1978 (1978).
5. Whitaker JN, Bashir RM, Chou C-HJ, Kibler RF. Antigenic features of myelin basic protein-like material in cerebrospinal fluid. J. Immunol. 124, 1148-1153 (1980).
6. Ohta M, Matsubara F, Konishi T, Nishitani H. Radioimmunoassay of myelin basic protein in cerebrospinal fluid and its clinical application to patients with neurological diseases. Life Sci. 27, 1069-1074 (1980). Reports a RIA system capable of measuring a MBP concentration as low as 500 ng/l.
7. Cohen SR, Brooks BR, Herndon RM, McKhann GM. A diagnostic index of active demyelination: Myelin basic protein in cerebrospinal fluid. Ann. Neurol. 8, 25-31 (1980).
8. Englert AB, Dommasch D, Hempel K. Myelin basic protein in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. J. Neurol. 225, 231-236 (1981).
9. Sellebjerg F, Christiansen M, Nielsen PM, Frederiksen JL. Cerebrospinal fluid measures of disease activity in patients with multiple sclerosis. Mult. Scler. 4, 475-479 (1998).
10. Whitaker JN. Myelin basic protein in cerebrospinal fluid and other body fluids. Mult. Scler. 4, 16-21 (1998). One of the review of MBP in CSF and other body fluids.
11. Ohta M, Ohta K, Ma J et al. Clinical and analytical evaluation of an enzyme immunoassay for myelin basic protein in cerebrospinal fluid. Clin. Chem. 46, 1326-1330 (2000). First report for an ELISA system measuring MBP in CSF with a detection limit of 30 ng/l. This convenient ELISA is a good indicator of MS disease activity.
12. Roman GC. The neuroepidemiology of tropical spastic paraparesis. Ann. Neurol. 23(Suppl.), 113-120 (1988).
13. Tournier-Lasserve E, Gout O, Gessain A et al. HTLV-I, brain abnormalities on magnetic resonance imaging and relation with multiple sclerosis. Lancet 2, 49-50 (1987).
14. Osame M, Matsumoto M, Usuki K et al. Chronic progressive myelopathy associated with elevated antibodies to human T lymphotropic virus Type I and adult T-cell leukemia like cells. Ann. Neurol. 21, 117-122 (1987).
15. Vernant JC, Maurs L, Gessain A et al. Endemic tropical spastic paraparesis associated with human T-lymphotropic virus Type I: a clinical and seroepidemiological study of 25 cases. Ann. Neurol. 21, 123-130 (1987).
16. Ohta M, Ohta K, Nishimura M, Saida T. Detection of myelin basic protein in CSF and serum from patients with HTLV-I associated myelopathy/tropical spastic paraparesis. Ann. Clin Biochem. (In Press).
17. Deibler GE, Martenson RE, Kies MW. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 2, 139-165 (1972).
18. Eylar EH, Brostoff S, Hashim G, Caccam J, Burnett P. Basic A1 protein of the myelin membrane. The complete amino acid sequence. J. Biol. Chem. 246, 5770-5784 (1971).
19. McPherson TA, Gilpin A, Seland TP. Radioimmunoassay of CSF for encephalitogenic basic protein: a diagnost test for MS? Can. Med. Assoc. J. 10, 856-859 (1972).
20. Murase K, Takeuchi R, Furukawa S, Hayashi K. Highly sensitive enzyme immunoassay for b-nerve growth factor (NGF): A tool for measurement of NGF in rat serum. Biochem. Int. 22, 807-813 (1990).
21. Jacque C, Delassalle A, Rancurel G, Raoul M, Lesourd B, Legrand J-C. Myelin basic protein in CSF and blood: Relationship between its presence and the occurrence of a destructive process in the brains of encephalitic patients. Arch. Neurol. 39, 557-560 (1982).
22. Ohta M, Nishitani H, Matsubara F, Inaba G. Myelin basic protein in spinal fluid from patients with neuro-Behcet's disease [LETTER]. New. Engl. J. Med. 302, 1093 (1980).
23. Nakagawa H, Yamada M, Kanayama T et al. Myelin basic protein in the cerebrospinal fluid of patients with brain tumors. Neurosurgery 34, 825-833 (1994).
24. van Engelen BG, Lamers KJ, Gabreels FJ, Wevers RA, van Geel WJ, Borm GF. Age-related changes of neuron-specific enolase, S-100 protein and myelin basic protein concentrations in cerebrospinal fluid. Clin. Chem. 38, 813-816 (1992).
25. Filippi M, Horsfield MA, Tofts PS, Barkhof F, Thompson AJ, Miller DH. Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis. Brain 118, 1601-1612 (1995).